| 中文名称 | 英文名称 | CAS号 | 化学式 |
|---|---|---|---|
| WITEGAOP079氟苯尼考胺标准品 | (1R,2S)-2-amino-3-fluoro-1-<4-(methylsulphonyl)phenyl>-1-propanol | 76639-93-5 | C10H14FNO3S |
| WHDS杂质1 | 3-(β-Aminoaethyl)-benzolsulfonamid | 81760-42-1 | C8H12N2O2S |
| WCK-5153R构型 | (2S,5R)-7-oxo-6-sulphooxy-2-[N’-((R)-pyrrolidine-3-carbonyl)-hydrazinocarbonyl]-1,6-diaza-bicyclo[3.2.1]octane | 1452459-94-7 | C12H19N5O7S |
| WB 4101盐酸盐 | 2-(2,6-dimethoxyphenoxyethyl)aminoethyl-1,4-benzodioxane | 613-67-2 | C19H23NO5 |
| WAY629盐酸盐 | 1,2,3,4,8,9,10,11-Octahydro-<1,4>-diazepino<6,5,4-jk>carbazol | 57756-45-3 | C15H18N2 |
| WAY208466二盐酸盐 | WAY-208466 | 633304-27-5 | C17H18FN3O2S |
| WAY 161503盐酸盐 | 8,9-dichloro-2,3,4,4a-tetrahydro-1H,6H-pyrazino[1,2-a]quinoxalin-5-one | 75704-24-4 | C11H11Cl2N3O |
| Voruciclib盐酸盐 | (+)-trans-2-(2-chloro-4-trifluoromethylphenyl)-5,7-dihydroxy-8-(2-hydroxymethyl-1-methylpyrrolidin-3-yl)chromen-4-one hydrochloride | 1000023-05-1 | C22H19ClF3NO5*ClH |
| Vicriviroc苹果酸盐;1-[(4,6-二甲基-5-嘧啶基)羰基]-4-[(3S)-4-[(1R)-2-甲氧基-1-[4-(三氟甲基)苯基]乙基]-3-甲基-1-哌嗪基]-4-甲基哌啶苹果酸盐 | 1-[(4,6-Dimethyl-5-pyrimidinyl)carbonyl]-4-[(3S)-4-[(1R)-2-methoxy-1-[4-(trifluoromethyl)phenyl]ethyl]-3-methyl-1-piperazinyl]-4-methylpiperidine malate | 541503-81-5 | C32H44F3N5O7 |
| Verucerfont; 3-(4-甲氧基-2-甲基苯基)-2,5-二甲基-N-[(1S)-1-(3-甲基-1,2,4-恶二唑-5-基)丙基]吡唑并[1,5-a]嘧啶-7-胺 | Verucerfont | 885220-61-1 | C22H26N6O2 |
| Verdinexor(KPT-335)抑制剂 | verdinexor | 1392136-43-4 | C18H12F6N6O |
| Val-cit-PAB-OH(VAL-CIT-PAB-羟基) | (S)-2-((S)-2-amino-3-methylbutanamido)-N-(4-(hydroxymethyl)phenyl)-5-ureidopentanamide | 159857-79-1 | C18H29N5O4 |
| Val-Ala对硝基苯胺乙酸盐 | Val-Ala p-Nitroanilide acetate salt | 108321-94-4 | C16H24N4O6 |
| VX-661中间体 | (2R)-1-[5-amino-2-[1-(benzyloxy)-2-methylpropan-2-yl]6-fluoro-1H-indol-1-yl]-3-(benzyloxy)propan-2-ol | 1294504-67-8 | C29H33FN2O3 |
| VX-661/VX6611-(2,2-二氟-1,3-苯并二氧戊环-5-基)-N-[1-[(2R)-2,3-二羟基丙基]-6-氟-2-(2-羟基-1,1-二甲基乙基)-1H-吲哚-5-基]-环丙烷甲酰胺 | (R)-1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)-N-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1H-indol-5-yl)cyclopropanecarboxamide | 1152311-62-0 | C26H27F3N2O6 |
| VUF11207三氟乙酸酯盐 | VUF11207 | 1378524-41-4 | C27H35FN2O4 |
| VU590二盐酸盐 | VU 590 dihydrochloride | 313505-85-0 | C24H34Cl2N4O7 |
| VU 0361737; N-(4-氯-3-甲氧基苯基)-2-吡啶甲酰胺 | VU0361737 | 1161205-04-4 | C13H11ClN2O2 |
| VTP-27999 盐酸盐 | VTP-27999 Hydrochloride | —— | C26H42Cl2N4O5 |
| VP/甲基丙烯酸二甲氨基乙酯共聚物 | 2-(Dimethylamino)ethyl 2-methylprop-2-enoate;1-ethenylpyrrolidin-2-one | 160984-81-6 | C14H24N2O3 |
| VP/二十碳烯共聚物 | 1-ethenylpyrrolidin-2-one;icos-1-ene | 28211-18-9 | C26H49NO |
| VP/VAc共聚物 | Pvp-VA | 25086-89-9 | C10H15NO3 |
| VP/DMAPA丙烯酸(酯)类共聚物 | N-[3-(dimethylamino)propyl]-2-methylprop-2-enamide;1-ethenylpyrrolidin-2-one;sulfuric acid | 175893-71-7 | C15H29N3O6S |
| VE烟酸酯 | alpha-tocopherol nicotinate | 51898-34-1 | C35H53NO3 |
| VER155008抑制剂 | VER155008 | 1134156-31-2 | C25H23Cl2N7O4 |
| VELPATASVIR中间体 | (3S,5S)-1-(tert-butoxycarbonyl)-5-(methoxycarbonyl)pyrrolidine-3-carboxylic acid | 1378388-35-2 | C12H19NO6 |
| VELPATASVIR 中间体 | (2S,5S)-1-((S)-2-(methoxycarbonylamino)-3-methylbutanoyl)-5-methylpyrrolidine-2-carboxylic acid | 1335316-40-9 | C13H22N2O5 |
| VEL 0230 | VEL-0230 | 221144-20-3 | C14H24NO5*Na |
| VEGFR2激酶抑制剂IV | 3-(thien-3-yl)-6-(4-methoxyphenyl)-pyrazolo(1,5-A)pyrimidine | 216661-57-3 | C17H13N3OS |
| VEGFR2激酶抑制剂II | VEGF Receptor 2 Kinase Inhibitor II | 288144-20-7 | C17H15BrN2O |
| VECTOMER?4051乙烯醚 | Bis[[4-(ethenoxymethyl)cyclohexyl]methyl] Benzene-1,4-dicarboxylate | 209072-72-0 | C28H38O6 |
| VCH-759(钠盐) | Vch759;vch 759 | 1001913-13-8 | C25H30NNaO4S |
| V-9-M缩胆囊素九肽 | Valyl-prolyl-valyl-glutamyl-alanyl-valyl-aspartyl-prolyl-methionine | 99291-20-0 | C42H69N9O14S |
| U型101017 | tert-butyl 7-chloro-5-[(cis-3,5-dimethylpiperazino)carbonyl]imidazo[1,5-a]quinoline-3-carboxylate | 170568-47-5 | C23H27ClN4O3 |
| Uprosertib,GSK2141795抑制剂 | N-{(1S)-2-amino-1-[(3,4-difluorophenyl)methyl]ethyl}-5-chloro-4-(4-chloro-1-methyl-1H-pyrazol-5-yl)-2-furancarboxamide | 1047634-65-0 | C18H16Cl2F2N4O2 |
| UmicoreM11催化剂 | 3-Phenyl-1H-inden-1-ylidene[bis(i-butylphobane)]ruthenium(II) dichloride | 894423-99-5 | C39H56Cl2P2Ru |
| UTP三钠盐 | Uridine 5'-triphosphate tetrasodium | 14264-46-1 | C9H11N2Na4O15P3 |
| UTP:Α-D-葡萄糖-1-磷酸尿苷酰基转移酶 | UTP---glucose-1-phosphate uridylyltransferase | 9026-22-6 | —— |
| USP杂质B | fluconazole | 81886-51-3 | C13H13FN6O |
| UR-144N-(5-羟基戊基) | (1-(5-hydroxypentyl)-1H-indol-3-yl)-(2,2,3,3-tetramethylcyclopropyl)methanone | 895155-95-0 | C21H29NO2 |
| UR-144N-(4-羟基戊基)代谢物 | UR-144 N(4-hydroxypentyl) | 1537889-04-5 | C21H29NO2 |
| UMICOREM52催化剂 | [1,3-bis(2,4,6-trimethylphenyl)-2-imidazolidinylidene]dichloro[2-(2-oxopropoxy)phenyl]methyleneruthenium(II) | 1014701-61-1 | C31H36Cl2N2O2Ru |
| UMI-77抑制剂 | UMI-77 | 518303-20-3 | C18H14BrNO5S2 |
| UK-148993,3羟基达非那新(非对映体混合物) | 2-[1-[2-(3-Hydroxy-2,3-dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl]-2,2-diphenylacetamide | 1285875-62-8 | C28H30N2O3 |
| UK 383367; 5-[(1R)-4-环己基-1-[2-(羟基氨基)-2-氧代乙基]丁基]-1,2,4-恶二唑-3-甲酰胺 | UK-383367 | 348622-88-8 | C15H24N4O4 |
| UDP葡萄糖-4-差向异构酶 | UDP-glucose 4-epimerase | 9032-89-7 | —— |
| UDP-葡萄醛酸三钠盐 | UDP-glucuronic acid (trisodium) (Standard) | —— | C15H19N2Na3O18P2 |
| UDP-N-乙酰半乳糖胺二钠盐 | UDP-GlcNAc Disodium Salt | 91183-98-1 | C17H25N3Na2O17P2 |
| UDP-D-葡萄糖(钠盐) | Uridine-dyphophate-glucose | 7333-33-7 | C15H24N2NaO17P2+ |
| U99194马来酸酯(PNU99194) | U-99194 maleate | 234757-41-6 | C21H31NO6 |